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WHAT THIS PAPER ADDS
 Even though snuffbox ﬁstulas have high patency rates published from centres familiar with the technique, many are reticent to
perform them or have published poor patency data for dialysed populations. While many factors have been associated with ﬁstula
failure, this paper is the ﬁrst to synthesise signiﬁcant factors into a score which would facilitate clinical decision making; not only
for creating a snuffbox ﬁstula but for identifying patients who are more suitable for a more proximal ﬁrst ﬁstula. If DISTAL can be
externally validated it could be an important step towards improving the renal registry data for ﬁstula prevalent populations.a r t i c l e i n f o
Article history:
Received 10 January 2012
Accepted 16 March 2012
Available online 17 April 2012
Keywords:
Arteriovenous ﬁstula
Vascular patency
Risk factor
Scoring method* Corresponding author. C.G. Davies, Heol Maes Egl
6NL, UK. Tel.: þ44 1792 702222; fax: þ44 1792 7022
E-mail address: chris.davies9@wales.nhs.uk (C.G. D
1078-5884/$ e see front matter  2012 European So
doi:10.1016/j.ejvs.2012.03.014a b s t r a c t
Objectives: A ﬁrst ﬁstula failing will lead to serious morbidity in a proportion of patients. Snuffbox ﬁstulas
have the advantage of proximal vessel preservation, and although several factors have been associated
with failure, the relative importance of these factors combined and their clinical applicability is
unknown. The aim of this study was to determine the relative importance of risk factors for snuffbox
ﬁstula failure and create a simple scoring system to aid ﬁstula placement decision making.
Methods: 218 consecutive patients were examined using Cox regression analysis to determine risk factors
for failure. Primary patency was used as the endpoint.
Results: Diabetes, IHD, Stroke, Two snuffbox procedures, Age > 70 and Less than 2.0 mm vein (DISTAL,
maximum score 6) were signiﬁcant predictors of primary patency failure. There was a clear decrease in
primary patency with increasing DISTAL score (log rank c2 ¼ 30.3, DF ¼ 5, P < 0.001). Performing
snuffbox procedures on patients with a score 3 would give a 23% reduction in the number of failures
within two months for a 12% reduction in the number of patients offered snuffbox procedures.
Conclusion: The DISTAL scoring system could give large improvements in primary patency for the
snuffbox ﬁstula if the results can be validated in other datasets.
 2012 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Introduction
The anatomical snuffbox ﬁstula may be the ﬁrst considered in
any patient requiring haemodialysis access. It was technically
possible in around 50% of patients in this unit and failure still leaves
several options for a ﬁstula available on that limb.1 Half of those
with failed snuffbox ﬁstulas will even be suitable for an ipsilateral
wrist radiocephalic ﬁstula.1wys, Morriston, Swansea SA6
23.
avies).
ciety for Vascular Surgery. PublishAlthough a one year primary patency of 65% is expected for
snuffbox ﬁstulas, 20% fail or fail to mature within six weeks.1,2 A
proportion of patients who require dialysis urgently will experi-
ence signiﬁcant morbidity as a result and subsequent central
venous catheter insertion is associated with signiﬁcant morbidity
and mortality, especially with long term use.3 Central venous
stenosis may also result and lead to a subsequent ﬁstula failure.
Patients who require dialysis urgently need a balance to be
struck between a high probability of ﬁstula success and the possi-
bility of future ﬁstula creation. For example, if a patient anatomi-
cally suitable for a snuffbox ﬁstula was known to have a very high
chance of failure, a wrist ﬁstula could be attempted instead.
Knowledge of risk factors for ﬁstula failure is required to guide thised by Elsevier Ltd. All rights reserved.
Table 1
Risk of failure of primary patency in relation to potential risk factors.
No. of patients HR (95% CI) P
Variables
Age > 70 98 vs 120 1.58 (1.04e2.42) 0.034
Second snuffbox procedure 12 vs 206 2.16 (0.93e5.00) 0.071
Venous diametera 2.0 mm 51 vs 167 1.56 (0.99e2.47) 0.056
IHD 136 vs 82 1.56 (1.00e2.42) 0.048
CVA 18 vs 200 1.76 (0.90e3.42) 0.096
Diabetes 52 vs 166 1.54 (0.97e2.43) 0.068
Non-signiﬁcant variables
Laterality L vs R 185 vs 33 1.06 (0.58e1.90) 0.860
Gender M vs F 164 vs 54 0.75 (0.47e1.18) 0.214
Arterial diametera 2.5 mmb 127 vs 91 0.80 (0.52e1.22) 0.298
Smoking 35 vs 183 0.51 (0.16e1.61) 0.250
PVD 31 vs 187 1.30 (0.57e2.99) 0.535
HR ¼ Hazard ratio from univariate Cox regression, P ¼ signiﬁcance of risk associa-
tion between the two cohorts, IHD ¼ Ischaemic heart disease,
CVA ¼ cerebrovascular disease, PVD ¼ Peripheral vascular disease.
a At anatomical snuffbox.
b Non-signiﬁcant at any strata.
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sively.4,5 Venous and arterial duplex ﬁndings are known to be
prognostically useful,6 and diabetes has been associated with
ﬁstula failure.7 However, few studies have attempted to rationalise
or combine the relative importance of individual factors associated
with ﬁstula failure. Furthermore, very little has been published
speciﬁcally on risk factors for the snuffbox ﬁstula. The aim of this
study was therefore to determine the relative importance of risk
factors for primary snuffbox ﬁstula failure. The endpoint was to
create a simple scoring system to aid ﬁstula placement decision
making.
Methods
Consecutive patients undergoing snuffbox ﬁstula formation at
Morriston Hospital, Swansea between 1st July 2007 and 1st July
2011 had details prospectively recorded for the UK Renal Registry
which conducts a prospective audit of results by unit performing
haemodialysis access procedures. Variables included patient
demographics, arterial and venous measurements, comorbidities
and operative details. Specialist dialysis access nurses also recorded
prospective data into a separate computer programme. Any data
missing from these databases were hand searched from patient
notes. Operations were performed by, or under the supervision of,
three specialist vascular surgeons. The criteria for decision making
for access planning and surgical technique has been published
previously.1
Fistula planning
All patients underwent a full preoperative arterial and venous
duplex within 2 weeks of the procedure and careful postoperative
follow up by specialist dialysis access nurses. A full decision making
protocol was published previously.1 Each year the unit performs
around 280 ﬁstulas, 70e75% of which were radial ﬁstulas. Of these,
around a third were snuffbox ﬁstulas (25% of all ﬁstulas).
If the ﬁrst snuffbox ﬁstula failed, choice of second ﬁstula sitewas
usually the ipsylateral wrist then forearm. Once there were no
further ipsilateral forearm options the contralateral snuffbox was
used for access if needed.
The focus of this study was on snuffbox ﬁstulas, so wrist ﬁstulas
were not examined. Arterial and venous diameter measurements
would have been different between the two procedures making
combined statistical analysis difﬁcult.
Score derivation
Due to the small size of the cohort and limited subsequent
limited statistical power we focussed on factors known to inﬂuence
primary patency.1,4,7 This was supplemented by an initial Cox
regression model examining all available variables. A history of
claudication, lower limb ulceration or ischaemic amputation were
considered as peripheral vascular disease (PVD). Ischaemic heart
disease (IHD) was deﬁned as any previous myocardial infarction,
proven angina and coronary vascular disease on angiography.
Cerebrovascular accident/Stroke (CVA) was deﬁned by a previous
CT proven infarct or haemorrhage. Diabetes included patients
taking insulin or oral hypoglycaemic agents. Smoking included
patients admitting to currently smoking. Antiplatelet use could not
be examined as all patients are commenced on them after ﬁstula
surgery.8 Covariates requiring stratiﬁcation were examined by
Kaplin Meier log rank analysis at bivariate strata around the
median, and the most signiﬁcant was chosen.
Patients who died before their ﬁstula was used (n ¼ 2) had
ﬁstula outcome truncated at time of death. The statistical power toperform reliable multivariate modelling was not available in this
dataset,9,10 so variables were chosen for inclusion by being
a univariate predictor of primary patency with a signiﬁcance of
p  0.1. Each signiﬁcant bivariate risk factor was allocated integer
values of 0 and 1, the overall predictive value being the sum.11,12
Statistical analysis appropriate for non-parametric data was
used. Cox’s proportional hazards logistic regression was used to
assess the prognostic value of individual covariates.13 Log rank
analysis from Kaplan Meier estimates were used to compare
survival for 5 years of follow up, but 2 year data is reported due to
the high attrition rate after this time.14 Data analysis was carried
out with the Statistical Package for Social Sciences (SPSS) version 16
(SPSS, Chicago, Illinois, USA). Ethical approval was sought from the
Regional Ethics Committee.
Results
Two hundred and eighteen patients underwent snuffbox ﬁstula
formation. The commonest causes of renal failurewere diabetes (34
patients, 15.6%), renovascular disease (41, 18.8%), idiopathic (30,
13.8%) and glomerulonephritis (30, 12.8%). The median patient age
was 69 (range 18e87). Thirty one (14%) of these failed within 2
months. A further 13 (6%) did not mature adequately for
haemodialysis and were therefore considered failed at 6 weeks.
Four patients had functioning ﬁstulas but did not require
haemodialysis. The remaining 170 (78%) matured without loss of
primary patency and were used for haemodialysis within 8 weeks
of construction.
Loss of primary patency and use of the ﬁstula for dialysis were
both assessed as endpoints by Cox regression. There were no
differences in variable outcomes between the two endpoints, with
less power in the latter group. Primary patency was therefore
chosen as the primary endpoint.
Loss of primary patency and score derivation
The median primary patency was 42 months. Cumulative 6
month 1 and 2 year patency was 69%, 61% and 53% respectively.
Table 1 shows the risk of loss of primary patency in relation to
potential risk factors. In addition, there was no difference in
primary patency by operating surgeon (HR ¼ 1.10 (0.79e1.52),
P ¼ 0.588). The most signiﬁcant age strata predicting failure was
70 years old (P ¼ 0.034). The most signiﬁcant venous diameter
strata predicting failure was 2.0 mm (P ¼ 0.032), and the most
Table 2
Primary patency failure associated with DISTAL score.
DISTAL No. of patients (%) Primary patency (%)
2 months 6 months 1 years 2 years
0 45 (20.6) 93 93 93 85
1 79 (36.2) 90 73 69 62
2 60 (27.5) 80 60 58 44
3 25 (11.5) 75 68 63 39
4 6 (2.8) 73 50 20 20
5 3 (1.4) 0 0 0 0
6 0 e e e e
Table 3
Risk of failure of primary patency in relation to DISTAL score.
DISTAL No. of patients (%) HR (95% CI) P
0e2 184 (84.4) 0.52 (0.31e0.86) 0.011
3 25 (11.4) 1.31 (0.99e1.73) 0.061
4e6 9 (4.2) 1.35 (0.98e1.78) 0.073
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most signiﬁcantly predicting loss of primary patency were:
a second, contralateral snuffbox ﬁstula after a ﬁrst snuffbox ﬁstula
and ipsilateral access had failed; venous diameter of 2.0 mm;
presence of IHD; previous CVA and diabetes. The resulting risk
score was therefore: Age > 70 years old ¼ 1; Second, contralateral
procedure ¼ 1; venous diameter 2.0 mm ¼ 1; IHD ¼ 1; CVA ¼ 1;
Diabetes ¼ 1. The score was termed DISTAL (Diabetes, IHD, Stroke,
Two snuffbox procedures (second, contralateral procedure),
Age > 70, Less than 2.0 mm vein). The maximum cumulative score
was 6.
Table 2 shows loss of patency associated with DISTAL score. The
three strata analysed were 0e2, 3 and 4e6. No patients scored 6.
There was a clear trend for decreasing primary patency by
increasing DISTAL score (log rank c2 ¼ 30.3, DF ¼ 5, P < 0.001).
Although the number of patients with DISTAL 4e6 were low (n¼ 9,
4.2%), primary patency between 2 and 6 months was far below the
65% suggested for commencement of haemodialysis.15 DISTAL 2
and 3 appear broadly comparable, however the number of patients
with a score of 3 was very low (n ¼ 25), and attrition above 6
months was high. DISTAL 3 was therefore considered separately
when grouping by score (Fig. 1). The three DISTAL strata were
examined using Cox regression to determine the risk of loss of
primary patency (Table 3).
Secondary patency and likelihood of ﬁstula salvage by DISTAL score
There was no signiﬁcant overall difference between primary and
secondary patency results. Sixteen (10%) of the 170 mature ﬁstulas
underwent intervention to maintain patency. Of those: twoFigure 1. Primary patency by grouped DISTAL score. Log rank c2 7.734, DF ¼ 2,
P ¼ 0.021.underwent open ﬁstulaplasty; three were proximalised to the
radial artery at thewrist; seven required ﬁstula outﬂowangioplasty
(six at the proximal forearm, one mid forearm) and four central
venous angioplasty. The DISTAL score in these patients was 1 (4
patients), 2 (6 patients) and 3 (6 patients). There was no relation-
ship between increasing DISTAL score and need for intervention
(P ¼ 0.546).Discussion
The most signiﬁcant factors associated with snuffbox ﬁstula
failure were grouped as the DISTAL score (Diabetes, IHD, Stroke,
Two snuffbox procedures, Age > 70, Venous diameter less than
2.0 mm). In this, the largest dataset published on snuffbox ﬁstulas,
a score of three or more was highly predictive of ﬁstula failure in
a patient in whom a snuffbox ﬁstula would technically be expected
to function.
Data was collected rigorously for national audit and is broadly
comparable to outcomes from the same unit 10 years previously.1
The fact that the risk factors in the DISTAL score have been previ-
ously independently reported to predict ﬁstula failure indicates
that the score is likely to have good external validity.4,7,16e20 Per-
forming snuffbox ﬁstulas in patients with a DISTAL score under 3
would result in 88% of these patients still being offered a primary
snuffbox ﬁstula with a 1 year patency of 71%. Additionally, for this
12% reduction in the number of snuffbox ﬁstulas performed, there
would be a 23% reduction in the number of early failures within 2
months. This implies that if the score could be validated in external
datasets it would have an important clinical impact on a ﬁstula
service.
From this data it is impossible to predict the fate of a wrist or
even brachiocephalic ﬁstula performed on a patient with a high
DISTAL score. It may be that these would also fail, and that these
patients are simply at high risk of ﬁstula loss. The predicted patency
savings may therefore be false, and this would have to be carefully
examined before the score was used clinically. If this proved to be
the case, the score could still be useful for predicting the ’at risk’
snuffbox ﬁstula which would merit more aggressive follow up. This
is the ﬁrst ever attempt to rationalise ﬁstula placement by a clini-
cally predictive score, and as such needs validating in large inde-
pendent external datasets before useful recommendations can be
made.
The difference in primary patency between patients scoring
DISTAL 2 and 3 is currently unclear. Patency was similar to 18
months, which may represent type II error in a small cohort of
patients. This could be examinedmore closely in a larger dataset, as
could the difference in primary patency under 6 months between
patients with a score of 3 and 4e6 (Fig. 1). The size of the dataset
meant that there was inadequate power for conditional Cox anal-
ysis to determinewhether the factors composing DISTAL were truly
independent. Univariate Cox regression is more accurate in this
situation, and was successfully shown to be when deriving the
original ABCD score for stroke risk after transient ischaemic attack
from a similar sample size.11 The score did not accurately predict
patients requiring intervention for maintenance of patency.
However, venous stenosis at sites of previous venous cannulation
was the underlying reason for intervention in the majority of
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factors in DISTAL.
In the previous study from this unit 10 years ago, female sex was
associatedwith amuch poorer patency of snuffbox ﬁstulas whereas
here it was not found to be an independent variable.21 This might
suggest that the poorer patency in women found previously was
related to vessel size which was not accurately assessed in the
previous study where most patients were selected on clinical
examination alone rather than on clinical and duplex information
together. This difference could also be attributed to bias from
a change in practice after the ﬁrst study was published, although
this was not perceived to be the case. Fistula laterality was also
found previously to inﬂuence outcome1 but was not an indepen-
dent variable here. This probably represents an increased failure
risk in second procedures (right sided) as was previously suggested.
There is evidence that diabetes and age4,22 may be associated with
ﬁstula failure. These formed part of the DISTAL score but were also
non-signiﬁcant 10 years ago.1 Both associations may be attributed
to error due to small sample size in either study or may reﬂect
changing patterns of disease. It was also surprising that smoking
and PVDwere not associatedwith failure in this study.7,17While not
all studies ﬁnd smoking and PVD to be signiﬁcant, of all risk factors
smoking is the most likely to be under reported and PVD under
diagnosed.
Whilst there are no comparable data for snuffbox ﬁstulas, the
overall patency rates in this study are higher than some of those
quoted in the literature for wrist ﬁstulas.4,23e25 Since the intro-
duction of both the US6 and UK15 guidelines there has been
controversy as to whether a high primary patency is achievable for
snuffbox or wrist ﬁstulas. Although there is the possibility that
these results are falsely high due to the retrospective collection of
a minority of the data, the patency rates from this unit were
remarkably consistent over the 10 years between studies.1 Addi-
tionally, some meta-analysed primary patency rates are in agree-
ment with these ﬁndings.2
The latest UK renal registry report shows that some UK units are
struggling to reach anAVﬁstula prevalent populationof greater than
85%, implying a difference between patency rates published in the
literature andUKclinical practice.26 This continuingdebate serves to
reinforce the need for further improvements in ﬁstula practice,
which a scoring system like DISTAL could be a step towards.
The increasing prevalence of haemodialysis27 makes it ever
important that the ﬁrst ﬁstula received by a patient functions
primarily and for a signiﬁcant period of time. The snuffbox ﬁstula
provides acceptable primary patency rates with the advantage of
preservation of proximal vessels for future access. Successful
primary patency of a snuffbox ﬁstula could be predicted by a score
based on the presence of Diabetes, IHD, Stroke, Two snuffbox
procedures, Age> 70 and Less than 2.0 mmvein (DISTAL). If DISTAL
can be externally validated it would be an important ﬁrst step
towards improving ﬁstula outcomes by rationalising placement.Conﬂict of Interest
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